Nyxoah (NYXH) has released an update.
Nyxoah SA, a medical tech company specializing in solutions for Obstructive Sleep Apnea, will be participating in the Jefferies Global Healthcare Conference on June 5-6, 2024, in New York. CEO Olivier Taelman will present at the conference, with a focus on their lead Genio system, which has already achieved European CE Mark and is pursuing FDA approval through ongoing studies.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
